Pancreatic Cancer
Digestive Cancers Europe/X

Promising Advances in Pancreatic Cancer: ASCO 2025 Highlights – Digestive Cancers Europe

Digestive Cancers Europe shared a post on X:

“Promising Advances in Pancreatic Cancer: ASCO 2025 Highlights

PANOVA-3 showed Tumour Treating Fields with chemotherapy improved survival and pain-free outcomes. CASSANDRA found PAXG extended event-free survival over mFOLFIRINOX.

TEDOPAM demonstrated that a cancer vaccine plus chemotherapy significantly improved one-year survival with minimally added toxicity for advanced disease.

Read more.”

More posts featuring Digestive Cancers Europe.